Clinical trials
Terminated Phase 1 Leukemia, Myelomonocytic, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2009 | 1 |
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 |
| Astex Pharmaceuticals, Inc. | 2 |
| University of Medicine and Dentistry of New Jersey | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Amgen | 1 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| Celgene Corporation | 1 |
| Erimos Pharmaceuticals | 1 |
| Fred Hutchinson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 22 |
| Myelodysplastic Syndromes | 18 |
| Leukemia, Myeloid, Acute | 17 |
| Leukemia | 8 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Myeloproliferative Disorders | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Hodgkin Disease | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Multiple Myeloma | 5 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.